The effects of intraarterial and intrahypothalamic injections of pituitary adenylate cyclase-activating polypeptide (PACAP) on the release of growth hormone (GH) were studied in PACAP infusion in rats12), whereas in humans, the serum GH levels did not change during a PACAP infusion1). In ewes, the infusion of PACAP into the cervical artery had no effect on GH release but an intracerebroventricular injection of PACAP suppressed GH release21). PACAP is widely distributed within neurons of the hypothalamus14,24), and specific PACAP binding sites are located centrally in regions including the hypothalamus and anterior pituitary gland4,5,16,25) We therefore suspected that PACAP can modify GH release in vivo by acting on both the hypothalamus and the adenohypophysis.
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a neuropeptide which stimulates adenylate cyclase activity in rat pituitary cells17,18). PACAP stimulates not only growth hormone (GH) release3,17,23) but also luteinizing hormone2,17), adrenocorticotropic hormone17) and prolactin17) release from rat pituitary cells in vitro. The effect of PACAP on the release of GH in vivo, in contrast, is still unclear. Serum GH levels increased more than 20-fold in response to an intravenous PACAP infusion in rats12), whereas in humans, the serum GH levels did not change during a PACAP infusion1). In ewes, the infusion of PACAP into the cervical artery had no effect on GH release but an intracerebroventricular injection of PACAP suppressed GH release21). PACAP is widely distributed within neurons of the hypothalamus14,24), and specific PACAP binding sites are located centrally in regions including the hypothalamus and anterior pituitary gland4,5,16,25) We therefore suspected that PACAP can modify GH release in vivo by acting on both the hypothalamus and the adenohypophysis.
We have shown that PACAP stimulates the GH release from bovine pituitary cells in vitro8-10,22) . In the present study, considering the controversial in vivo results, we investigated whether PACAP stimulates the release of GH in ruminants in vivo. First, we tested whether PACAP has a direct effect on GH release in intact goats by injecting the peptide into the cervical artery. Secondly, we investigated the possible central role of PACAP on GH secretion by injecting it into the hypothalamus in intact goats.
Materials and Methods

Animals
Four female Saanen goats in the luteal phase (age, 2-3 years; mean body weight, 46kg) were used. Each goat was loosely tied to a stanchion in an animal pen, and natural light entered through the windows. The goats were fed hay and concentrate from 0830 to 0930h and from 1630 to 1730h daily. Water was available continuously.
On the experimental day, they were not fed before or during the experiment, but were fed after the experiment.
Preparation of pituitary adenylate cyclaseactivating polypeptide
Pituitary adenylate cyclase-activating polypeptide with 27 amino acid residues (PACAP) was used in the present study. The peptide was generously supplied by Dr. S. Ohashi, National Institute of Bioscience and Human Technology, Tsukuba, Japan. The PACAP was dissolved in sterilized 0.9% NaCl (saline) before use.
Intraarterial injection experiment An indwelling catheter for the infusion of PACAP was surgically inserted into one of the cervical arteries in three goats at least 1 week before the experiment.
The goats were given kg body weight (BW) of PACAP dissolved in 2 ml saline. Two ml saline vehicle alone was injected as a control. The injection was given 30min after the onset of blood collection each day. The experiment was performed at 4-or 5 -day intervals in each goat . The order in which each goat received the various dosages was determined at random.
Intrahypothalamic injection experiment Unilateral guide tubes were stereotactically implanted into the hypothalamus in four goats at least 2 weeks before the first experiment. Anesthesia was initiated by intravenous xylazine hydrochloride (35mg/head) and maintained by inhalation of halothane through an endotracheal tube. The procedures of surgical implantation of the guide tubes were described in detail17,11). Three of these four goats were used in the intraarterial injection experiment.
On the day of the experiment, an infusion cannula was inserted into the imreleasing activity of this dosage had already been confirmed in our preliminary study in the goat. The infusion was given 30min after the onset of blood collection each day. The experiment was performed at the same site in the hypothalamus at 4-or 5-day intervals in each goat. The order in which each goat received the various dosages was determined at random. At the termination of experiments, each goat was anesthetized with intravenous pentobarbital sodium, and the placement of the probe in the brain was histologically confirmed7,11).
Blood sampling method The jugular venous blood of the experimental animals was taken from the indwelling catheter previously inserted into one of the external jugular veins. Blood samples (one ml each) were collected into centrifuge tubes containing heparin and immediately chilled with ice. Blood samples were drawn at 10-min intervals for 180min. Individual plasma samples were obtained after centrifugation and The area under the GH response curve (AUC) for 2.5h (150min) after the injection of PACAP was calculated. The significance of differences between the values pre-injection and post-injection of PACAP and the AUCs in each group was determined by Student's t-test or the Cochran-Cox test after analysis of the uniformity of the variances by Bartlett's test26).
Results were considered significant at the P< 0.05 level.
Results
A single intraarterial injection of PACAP increased the respiration rate and heart rate twoor threefold after the injection, and these responses continued for about 20min. Skin flushing was also observed after the intraarterial injection. These responses seemed to occur in a dose-dependent manner, and the BW of PACAP was injected. In contrast to the results of intraarterial injection, the intrahypothalamic injection of PACAP had no effect on the respiration rate, heart rate and skin flushing.
The responses of plasma GH in goats to a kg BW of PACAP and that of saline are shown in Fig. 1 . The mean plasma GH concentra- tions in the saline-injected control goats varied within the range of 4.1 to 8.8ng/ml, and no significant changes in the plasma GH levels were observed throughout the experiment. PACAP injection were significantly higher than the pre-PACAP concentrations (P<0.05). The AUCs for 2.5h after the intrahypothalamic (Fig. 4) . The areas into which we infused the test agent in 3 (#1, #2, #3) of 4 goats were 1 to 2mm lateral to the midline of the third ventricle, and 1 to 2mm above the optic chiasm. These sites were in the preoptic area. The area into which we infused the test agent in a goat (#4) was 0.5mm lateral to the midline of the third ventricle in the region of the mediobasal hypothalamus.
Discussion
The results described above showed that PACAP stimulated the release of GH in goats in vivo. To our knowledge, the present study is the first demonstration of the effect of PACAP in stimulating GH release in goats.
The stimulatory effect of PACAP on the release of GH following an intraarterial injection was consistent with the report of Jarry et al.12), who showed that serum GH levels increased more than 20-fold in response to an intravenous PACAP infusion in rats. However, Chiodera et al.1) and Sawangjaroen and Curlewis21) found no stimulatory effect of PACAP on the release of GH after the intravenous or intraarterial PACAP infusion in humans and ewes. The reason for the discrepancy between their results and ours could be due to the differences in the dosages of PACAP used in each study. The maximum dosages infused in their experiments were 8pmol/kg/ min for 20min1) and 1.0nmol/min for 10min21). Those dosages might have been too small to stimulate GH release in vivo. PACAP injected into the cervical artery is thought to act mainly at the anterior pituitary level. Our results obtained with intraarterial injections therefore suggest that PACAP is one of the hypophysiotropic factors in hormone secretions of the goat.
Sawangjaroen and Curlewis21) reported that the intracerebroventricular (ICV) injection of PACAP suppressed GH secretion in ewes. In our present microinjection study, the intrahypothalamic injection of PACAP stimulated the GH release. The target site of the brain in the ICV injection method is not known, even if the administered substances modify pituitary hormones by acting indirectly on the pituitary gland. The reason for the discrepancy between their results and ours might be due to the differences in the brain sites affected by PACAP.
The GH-releasing responses after intrahypothalamic injection of PACAP were delayed when compared with intraarterial injections of the peptide. Intraarterial PACAP was thought to be able to easily reach the adenohypophysis by the bloodstream, and promptly stimulate somatotrophs to release GH. In contrast, injected PACAP into the hypothalamus was thought to be necessary to stimulate growth hormone-releasing hormone (GHRH) secretion, reduce somatostatin (SS) or both to release GH. Furthermore, there is a need of intrahypothalamic PACAP to have access to some neurons to increase GHRH and reduce SS or both. The injected sites of PACAP in the present study might not be adjacent to these neurons, and GH-releasing responses after intrahypothalamic injection of the peptide might be delayed. There is also another possibility that intrahypothalamic PACAP directly stimulated the somatotroph to release GH after the traversing of the hypothalamic tissues.
The single intraarterial injection of PACAP in the present study produced physical changes such as skin flushing, increased respiration rate and heart rate. Similar effects were reported when PACAP was infused into the cervical artery in sheep20). These effects did not seem to be a central action, since these changes did not occur when PACAP was injected into the hypothalamus. Specific PACAP binding sites are located not only in the hypothalamus and pituitary gland 4,5,16,25) but also in various tissues including the lung and blood vessels4,19). Therefore, PACAP appears to have functions in various tissues, including a role in pituitary hormone secretions.
In summary, the present results suggest that PACAP stimulates the GH release in goats by acting not only directly on the adenohypophysis but also indirectly through the hypothalamus.
However, the detailed mechanism by which PACAP stimulated GH release through the hypothalamus remains unclear.
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